Chairman Amit Bakshi credits pitching Sundae as a diabetes drug first. Eris also has approval to trial what it calls India's first in-house recombinant semaglutide.
Recap by typeshit. Full story at Moneycontrol.
A Weird Science riff frames her before and after, crediting GLP-1 medication for taking her from 233 pounds down to 133.
The Post digs into how weight loss on GLP-1 drugs may be affecting marriages, and finds the answer is not simple.
She explains that GLP-1 drugs copy a hormone the body already makes, and says they can curb appetite, slow digestion and help with blood sugar.
She landed the Daily Mail front page this week discussing Ozempic face and the steps she says she took to protect her own.
He points to GLP-1s as proof, citing his figure that 1 in 9 American adults now use one for weight loss.
Per @pamelajeannoble, the letter flags contamination risks, manufacturing conditions and compounded copies resembling approved drugs.
Loading…